Athyrium Opportunities Associates III GP LLC

Director, 10% OwnerBIORA THERAPEUTICS, INC. (BIOR) · full profile →Form 4 · filed Aug 14, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
0 non-derivative · 12 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 12, 2024Grant(A)0
Aug 12, 2024Disposed to issuer(D)0
Aug 12, 2024Disposed to issuer(D)500K0
Aug 12, 2024Grant(A)457K457K
Aug 12, 2024Disposed to issuer(D)324K0
Aug 12, 2024Grant(A)324K324K
Aug 12, 2024Disposed to issuer(D)457K0
Aug 12, 2024Grant(A)500K500K
Aug 12, 2024Disposed to issuer(D)2.1M0
Aug 12, 2024Grant(A)2.1M2.1M
Aug 12, 2024Disposed to issuer(D)5.0M0
Aug 12, 2024Grant(A)5.0M5.0M

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-097355) within minutes of acceptance. Every field above traces to the original document. Verify it directly: